Mosaicbio
Boulder, US · Founded 2009 · Delaware corporation · 46 employees on LinkedIn · 1 known investors
Mosaic Biosciences is a biologics discovery company that advances biologic drug candidates from discovery through IND-enabling studies and clinical development, working with partners across multiple therapeutic modalities. Its services span protein design and engineering, antibody discovery, and data science for therapeutic programs.
Founders & leadership
Mosaicbio was founded in 2009 by Marty (Martin) Stanton.
M(
Marty (Martin) StantonFounder & former CEO
EF
Eric FurfineChief Scientific Officer
AK
Alexei KazantsevVice President Protein Design and Engineering
TM
Tracey MullenChief Strategy Officer
SG
Scott GlaserSVP, Biologics Discovery
JW
Jean-Pierre WeryChief Executive Officer
DM
Dan MitchellNamed on SEC filing
MS
Martin StantonNamed on SEC filing
Board
RC
JW
AL
Augustine LawlorBoard director
ML
Mark LupaBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$13.7M disclosed across 2 rounds · 2014–2022
▶$11.4MraisedJan 2023 · 4 investors · BiotechnologyRule 506(b)
▶$11.4MraisedJan 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rob CaponeDirector
- Jeanette WelshDirector
- Dan MitchellDirector
- Martin StantonExecutive Officer, Director
- Eric FurfineDirector
- Offering amount
- $11.4M
- Amount sold
- $11.4M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedFeb 2014 · 4 investors · BiotechnologyRule 506(b)
▶$2.3MraisedFeb 2014 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Augustine LawlorDirector
- Martin StantonExecutive Officer, Director
- Guy KatsavDirector
- Nassim UsmanDirector
- Mark LupaDirector
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Mosaicbio do?
- Mosaic Biosciences is a biologics discovery company that advances biologic drug candidates from discovery through IND-enabling studies and clinical development, working with partners across multiple therapeutic modalities. Its services span protein design and engineering, antibody discovery, and data science for therapeutic programs.
- Who founded Mosaicbio?
- Mosaicbio was founded by Marty (Martin) Stanton in 2009.
- Who are Mosaicbio's investors?
- Mosaicbio's investors include Telegraph Hill Partners.
- How much funding has Mosaicbio raised?
- Mosaicbio has disclosed $13.7M raised across 2 rounds.
- Where is Mosaicbio headquartered?
- Mosaicbio is headquartered in Boulder, US.